Disease/Infection News

RSS

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

In a major new discovery that might deepen our understanding of SARS-CoV-2’s animal origins and its genetic evolution, coronaviruses very closely related to SARS-CoV-2 have been discovered in two horseshoe bats outside of China.

25 Nov 2020

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

A recent study based at a hospital in Buenos Aires, Argentina, found that convalescent plasma therapy for patients with severe COVID-19, and COVID-19-related pneumonia, was largely ineffective.

25 Nov 2020

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

Researchers from the Centres for Disease Prevention and Control (CDC) have released findings of their study on the transmission of SARS-CoV-2 via international travel.

25 Nov 2020

Why employers find it so hard to test for COVID

Brandon Hudgins works the main floor at Fleet Feet, a running-shoe store chain, for more than 30 hours a week. He chats with customers, measuring their feet and dashing in and out of the storage area to locate right-sized shoes. Sometimes, clients drag their masks down while speaking. Others refuse to wear masks at all.

25 Nov 2020

Researchers describe important cause of fatal influenza

It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. Researchers at Karolinska Institutet in Sweden have now described important findings leading to so-called superinfections, which claim many lives around the world every year.

25 Nov 2020

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

Researchers report SARS-CoV-2 antibodies to the spike protein (S protein) can persist 200 days after symptom onset, but that antibodies to the nucleoprotein (N protein) can reduce much more rapidly.

25 Nov 2020

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

Dr. Albert Rizzo speaks to News-Medical about the importance of wearing masks to help control the spread of COVID-19.

25 Nov 2020

Is COVID-19 severity mediated by higher antibody response?

A new study indicates that patients with more severe COVID-19 have a stronger antibody response.

25 Nov 2020

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

A study conducted by researchers based in Italy suggests that SARS-CoV-2 induces durable and strong immunity in patients who had moderate to severe COVID-19.

25 Nov 2020

Researchers review key elements of crisis decision making during public health emergencies

In mid-March, public health officials across the San Francisco area issued the first U.S. regional shelter-in-place order in response to the emerging COVID-19 pandemic.

25 Nov 2020

Germicidal lamps used to sanitize against COVID-19 may damage the cornea

In a paper published in the journal of Ocular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus.

25 Nov 2020

Consistent use of face masks slows the spread of COVID-19

The use of face masks to help slow the spread of COVID-19 has been widely recommended by health professionals.

25 Nov 2020

Researchers develop lung-on-chip model to study the body’s response to early TB

Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.

25 Nov 2020

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

An interesting study published on the preprint server medRxiv in November 2020, dealing not with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is the cause of the COVID-19 pandemic, but with the publications that have appeared as a consequence of the outbreak, comparing them with the similar trove of publications that followed the Zika virus outbreak in 2016.

25 Nov 2020

Bariatric surgery linked to lower risk of hospital and intensive care unit admission

A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission.

24 Nov 2020

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

In the face of discouraging news about the resurgence of COVID-19, some reports offer hope of protection in the face of a robust and persistent immune response. In an encouraging report, an Austrian preprint appearing on the medRxiv server in November 2020 suggests a high level of durable immunity to SARS-CoV-2 over at least six months.

24 Nov 2020

Scientists use demographic data to estimate test-based case fatality rates across California

A team of UCLA Fielding School of Public Health researchers has developed analyses to identify those most at risk from the pandemic, using demographic data to estimate test-based infection and test-based case fatality rates across California.

24 Nov 2020

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

Recently, researchers from the Monash University and Monash Medical Centre, Clayton, Victoria, Australia, investigated whether peptide sensitization using BCG can produce cross-reactive T cells specific to SARS-CoV-2. Their study is published on the preprint server, medRxiv.

24 Nov 2020

A review of Traditional Chinese herbal medicine in management of COVID-19

Now researcher have summarized the experiences with the use of traditional Chinese herbal medicines for the management of COVID-19. Their study titled, “Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis,” was published in the January 2021 issue of the journal Phytomedicine.

24 Nov 2020

New therapy for flu may prove effective against many other pathogenic virus infections

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

24 Nov 2020

Disease/Infection News

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

Why employers find it so hard to test for COVID

Researchers describe important cause of fatal influenza

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

Is COVID-19 severity mediated by higher antibody response?

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

Researchers review key elements of crisis decision making during public health emergencies

Germicidal lamps used to sanitize against COVID-19 may damage the cornea

Consistent use of face masks slows the spread of COVID-19

Researchers develop lung-on-chip model to study the body’s response to early TB

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

Bariatric surgery linked to lower risk of hospital and intensive care unit admission

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

Scientists use demographic data to estimate test-based case fatality rates across California

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

A review of Traditional Chinese herbal medicine in management of COVID-19

New therapy for flu may prove effective against many other pathogenic virus infections

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News